Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets.
about
Centrosome amplification in chondrosarcomas: A primary cell culture and cryopreserved tumor sample study.microRNA and Bone Cancer.miR-125b acts as a tumor suppressor in chondrosarcoma cells by the sensitization to doxorubicin through direct targeting the ErbB2-regulated glucose metabolism.Inhibition of Src by microRNA-23b increases the cisplatin sensitivity of chondrosarcoma cells.Response to sunitinib in combination with proton beam radiation in a patient with chondrosarcoma: a case report.ETV5 as a regulator of matrix metalloproteinase 2 in human chondrosarcoma.MAPK/ERK Signaling in Osteosarcomas, Ewing Sarcomas and Chondrosarcomas: Therapeutic Implications and Future Directions.Dedifferentiated Chondrosarcoma of Proximal Tibia and Fibula with an Infected Ulcer: A Case Report.Development and characterization of a human three-dimensional chondrosarcoma culture for in vitro drug testing.99mTc-NTP 15-5 assessment of the early therapeutic response of chondrosarcoma to zoledronic acid in the Swarm rat orthotopic model.Symptomatic loosening of a total knee arthroplasty caused by a tibial chondrosarcoma - a case report.Description of the immune microenvironment of chondrosarcoma and contribution to progression.Chondrosarcoma: A Rare Misfortune in Aging Human Cartilage? The Role of Stem and Progenitor Cells in Proliferation, Malignant Degeneration and Therapeutic Resistance.BAG3 promotes chondrosarcoma progression by upregulating the expression of β-catenin.FOXA1 transcriptionally up-regulates cyclin B1 expression to enhance chondrosarcoma progression
P2860
Q33598647-C7EFBB59-1884-4B0D-8959-AA400EF8D961Q38667026-51E94079-0C45-414A-A7EE-4215075F9D03Q38680966-ACC5E8C0-3A8D-4117-8BE0-DBCDD83D15A9Q38721488-68D163EC-B109-4F3F-860E-74F026EC8B86Q39252570-F3E65944-9D08-4B1E-8E7F-4DF04FAB43B2Q39280850-563083FB-E3CA-41A8-BD73-5FEA26AC7F27Q39618772-2F7C7FDE-45AB-44AB-B48C-EA0773AA3D23Q40516802-93A2D38B-4FA2-44F3-8804-D9D783B10230Q41007674-4D90C8E3-E1C9-45AF-80DA-1C7B6E78BE0CQ41104372-DB386248-9A98-49EA-A162-A2055A609A07Q41838485-D8825E1E-1BAB-4CDD-B2D9-FE085AE4BD57Q46532764-2588E636-0518-40C9-A71F-532EE18F8221Q48182725-98A2EF63-6AC4-48F6-B3F4-2567ECD44C0FQ52684027-F4AD0CB1-1C7E-4A6C-A106-9614A32A2004Q58790055-46E694EF-B1E7-448D-B549-F5E4776D4F11
P2860
Surmounting chemotherapy and radioresistance in chondrosarcoma: molecular mechanisms and therapeutic targets.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 December 2010
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Surmounting chemotherapy and r ...... nisms and therapeutic targets.
@en
Surmounting chemotherapy and r ...... nisms and therapeutic targets.
@nl
type
label
Surmounting chemotherapy and r ...... nisms and therapeutic targets.
@en
Surmounting chemotherapy and r ...... nisms and therapeutic targets.
@nl
prefLabel
Surmounting chemotherapy and r ...... nisms and therapeutic targets.
@en
Surmounting chemotherapy and r ...... nisms and therapeutic targets.
@nl
P2093
P2860
P356
P1433
P1476
Surmounting chemotherapy and r ...... nisms and therapeutic targets.
@en
P2093
Alexander M Hincker
Anne C Onishi
Francis Y Lee
P2860
P304
P356
10.1155/2011/381564
P577
2010-12-30T00:00:00Z